Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2009-07, Vol.374 (9683), p.26-26
Main Authors: Segura, J, Ruilope, LM
Format: Article
Language:English
Subjects:
C-Reactive Protein - metabolism
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Cholesterol, LDL - blood
Fluorobenzenes - therapeutic use
Glomerular Filtration Rate
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Internal Medicine
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - diagnosis
Pyrimidines - therapeutic use
Research Design
Risk Reduction Behavior
Rosuvastatin Calcium
Sulfonamides - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(09)61233-2